International Handbook on Regulating Nanotechnologies 2010
DOI: 10.4337/9781849808125.00021
|View full text |Cite
|
Sign up to set email alerts
|

Approaching the Nanoregulation Problem in Chemicals Legislation in the EU and US

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2010
2010
2018
2018

Publication Types

Select...
2
2

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 0 publications
0
2
0
Order By: Relevance
“…However, it is now commonly agreed that REACH presents several shortcomings as far as nanomaterials are concerned. [3, p. 6], most of the policy and guidance work strives toward better implementation of REACH to nanomaterials [9]. This entails that it does not take into account the specific hazards that can be caused by the specific properties of materials once they reach the nanoscale.…”
Section: Legislation On Chemical Products (Reach) and The Role Of Casmentioning
confidence: 99%
“…However, it is now commonly agreed that REACH presents several shortcomings as far as nanomaterials are concerned. [3, p. 6], most of the policy and guidance work strives toward better implementation of REACH to nanomaterials [9]. This entails that it does not take into account the specific hazards that can be caused by the specific properties of materials once they reach the nanoscale.…”
Section: Legislation On Chemical Products (Reach) and The Role Of Casmentioning
confidence: 99%
“…Governments in leading industrialized countries are currently relying on existing frameworks for EHS regulation to deal with nanotechnology risks, making minor adjustments to specifi c regulations and their implementation in order to close any potential gaps or eliminate uncertainties. These challenges and governments' responses to them are discussed in more detail by, for example, Widmer and Meili (2010) in relation to industrial chemicals, van Calster and Bowman (2010) in relation to the use of nanomaterials in cosmetic products and Gaspar (2010) in relation to therapeutic products. 3 Regulators face a number of challenges in dealing with the potential risks of nanomaterials.…”
Section: Regulatory Challenges Of Nanomaterialsmentioning
confidence: 99%